GeneDx Holdings Corp. has grown revenue 26% a year over three years and 18% a year over five. Revenue growth, 3-year annual rate: +26% (Diagnostics & Research median +9.1%). Revenue growth, 5-year rate: +18%, growth has picked up over the last three years. Years of annual history on file: 7, FY2019 to FY2025, as filed.

WGSGeneDx Holdings Corp.

HealthcareUSD

$90.35

$34.5152 weeks$167.51

Is it growing?

Is WGS growing?

GeneDx Holdings Corp. has grown revenue 26% a year over three years and 18% a year over five.

+26%

Revenue growth, 3-year annual rate · Diagnostics & Research median +9.1% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +18%
Revenue growth, 5-year rate · +26% over three · growth has picked up over the last three years
Years of annual history on file: 7
Years of annual history on file · FY2019 to FY2025, as filed

Details›